ACTIVE

ABBOTT MEDICAL BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result33,8 k €-99,1 %over 1 year
Revenue85,5 M €+9,6 %over 1 year
Equity13,3 M €+0,3 %over 1 year
Workforce75,4 ETP-3,2 %over 1 year

Identity

Source · BCE/KBO

ABBOTT MEDICAL BELGIUM is a Public limited company incorporated in 1990. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Zaventem. It employs on average 75,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0441.665.942
Incorporation
28/09/1990
Legal form
Public limited company
Registered office
Da Vincilaan 11 box F1
1930 Zaventem · FlandreSee on map
Contributed capital
6 028 061,00 €
Latest accounts
31/12/2025
Average workforce
75,4 ETP
Joint committees (2)
  • 14904
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 21 filings

Trend over 8 financial years

20252024202320212020
Income statement
Revenue85,5 M €78 M €77,1 M €72,3 M €63,3 M €
EBITDA2,9 M €4,1 M €3,1 M €2,6 M €2,2 M €
Operating result2,6 M €3,3 M €2,4 M €1,9 M €1,7 M €
Net result33,8 k €3,7 M €1,4 M €1,1 M €479,4 k €
Balance sheet
Equity13,3 M €13,3 M €9,4 M €15,6 M €14,5 M €
Total assets40,8 M €31 M €29,3 M €30,1 M €31,1 M €
Cash––3,8 k €–327,6 €
Debts25,2 M €15,8 M €17,5 M €11,2 M €14,2 M €
Other
Workforce75,4 ETP77,9 ETP78,8 ETP85,0 ETP86,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 10 ended

Active mandates

Tim Demaerschalk

Director · since 01 janvier 2026 · until 30 juin 2032

Active
Bradley Jay Slater

Director · since 28 octobre 2022 · until 30 juin 2029

Active

Ended mandates

Hendrikus LUEB

Director · since 13 février 2020 · until 15 mai 2026

Ended
Lueb Hendrikus A.M.

Director · since 13 février 2020 · until 15 juin 2026

Ended
Jan Gerrit Van De Hoef

Director · since 11 janvier 2019 · until 20 mai 2026

Ended
Davy Rogge

Director · since 10 janvier 2019 · until 20 mai 2022

Ended

Other companies at this address

Da Vincilaan 11 1930 Zaventem
CompanyCBE no.
Abbott Belgian Pension Fund● Active
0422.418.370
Abbott Rapid Diagnostics● Active
0455.002.056
GARTNER BELGIUM● Active
0467.335.013
OPEN PIXEL SYSTEMS● Active
0751.900.448
St. Jude Medical Coordination Center● Active
0888.256.714
TMC Science & Technology● Active
0544.895.718

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/07/202604/12/202510/07/202425/07/202330/06/202226/07/2021
General meeting30/06/202627/06/202528/06/202430/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202603/07/2026DutchPDF
Full modelCorrection31/12/202427/06/202504/12/2025DutchPDF
Full model31/12/202427/06/202507/07/2025DutchPDF
Full model31/12/202328/06/202410/07/2024DutchPDF
Full model31/12/202230/06/202325/07/2023DutchPDF
Full model31/12/202130/06/202230/06/2022DutchPDF
Full model31/12/202030/06/202126/07/2021DutchPDF
Full model31/12/201907/09/202008/09/2020DutchPDF
Full model31/12/201831/10/201919/11/2019DutchPDF
Full model31/12/201712/11/201815/11/2018DutchPDF
Full model31/12/201630/06/201729/11/2017DutchPDF
Full model31/12/201520/05/201630/06/2016DutchPDF
Full model31/12/201429/05/201509/07/2015DutchPDF
Full model31/12/201327/06/201430/07/2014DutchPDF
Full model31/12/201228/06/201325/07/2013DutchPDF
Full model31/12/201106/08/201213/08/2012DutchPDF
Full model31/12/201031/10/201124/11/2011DutchPDF
Full model31/12/200919/11/201006/12/2010DutchPDF
Full model31/12/200830/11/200906/01/2010DutchPDF
Full model31/12/200724/10/200816/01/2009DutchPDF
Full model31/12/200618/05/200727/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 10 ended

Active mandates

Tim Demaerschalk

Director · since 01 janvier 2026 · until 30 juin 2032

Active
Bradley Jay Slater

Director · since 28 octobre 2022 · until 30 juin 2029

Active

Ended mandates

Hendrikus LUEB

Director · since 13 février 2020 · until 15 mai 2026

Ended
Lueb Hendrikus A.M.

Director · since 13 février 2020 · until 15 juin 2026

Ended
Jan Gerrit Van De Hoef

Director · since 11 janvier 2019 · until 20 mai 2026

Ended
Davy Rogge

Director · since 10 janvier 2019 · until 20 mai 2022

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates16/01/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/11/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/11/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/11/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/04/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/02/2022
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202533,8 k €↓
  2. 2024
    Annual accounts 20243,7 M €↑
  3. 2023
    Annual accounts 20231,4 M €↑
  4. 2021
    Annual accounts 20211,1 M €↑
  5. 2020
    Annual accounts 2020479,4 k €↓
  6. 2019
    Annual accounts 20192,1 M €↑
  7. 2018
    Annual accounts 20181,6 M €↑
  8. 2017
    Annual accounts 2017362,9 k €
  9. 28/09/1990
    IncorporationPublic limited company